Basics |
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
|
IPO Date: |
April 2, 1991 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$59.16B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$4.24 | 1.81%
|
Avg Daily Range (30 D): |
$7.61 | 1.42%
|
Avg Daily Range (90 D): |
$9.70 | 1.70%
|
Institutional Daily Volume |
Avg Daily Volume: |
.66M |
Avg Daily Volume (30 D): |
.82M |
Avg Daily Volume (90 D): |
.98M |
Trade Size |
Avg Trade Size (Sh.): |
64 |
Avg Trade Size (Sh.) (30 D): |
27 |
Avg Trade Size (Sh.) (90 D): |
29 |
Institutional Trades |
Total Inst.Trades: |
11,115 |
Avg Inst. Trade: |
$18M |
Avg Inst. Trade (30 D): |
$33.84M |
Avg Inst. Trade (90 D): |
$40.08M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$35.66M |
Avg Closing Trade (30 D): |
$76.79M |
Avg Closing Trade (90 D): |
$90.31M |
Avg Closing Volume: |
72.44K |
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$41.77
|
$7.58
|
$8.54
|
Diluted EPS
|
$39.33
|
$7.27
|
$8.11
|
Revenue
|
$ 14.09B
|
$ 3.03B
|
$ 3.79B
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ 4.5B
|
$ 808.7M
|
$ 917.7M
|
Operating Income / Loss
|
$ 3.83B
|
$ 591.7M
|
$ 990.2M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ 483.2M
|
$ 604M
|
$ 477.2M
|
PE Ratio
|
14.51
|
|
|
|
|
|